Tuesday, June 5, 2007

UPDATE 1-Quark Pharma sets IPO of 5 mln shares at $12-$14 each

(Reuters) - The company said it would use the net proceeds to fund
research and product development activities as well as for
general administrative activities and working capital.




JPMorgan, Banc of America Securities, CIBC World Markets
and C.E. Unterberg, Towbin are underwriting the IPO.


Read more at Reuters.com Bonds News

No comments: